Mahesh Patel

(Dr. Mahesh Patel Ph.D.)

Currently holds a position at Lipocine Inc

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Lipocine Inc Jan. 6, 2014 -
President, Chief Executive Officer, Director Lipocine Inc July 24, 2013 - Jan. 6, 2014
Mahesh Patel's trades of Lipocine Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-25 2023-05-25
US Lipocine Inc (LPCN)
B Purchase
8,706 +8.8%
5.03
USD 43,791 		8,706 +8.8% 5.03 USD 43,791
2023-03-24 2023-03-24
US Lipocine Inc (LPCN)
B Purchase
150,000 +9.8%
0.32
USD 48,000 		150,000 +9.8% 0.32 USD 48,000
2023-03-17 2023-03-17
US Lipocine Inc (LPCN)
B Purchase
50,000 +3.4%
0.33
USD 16,500 		50,000 +3.4% 0.33 USD 16,500
2022-11-14 2022-11-14
US Lipocine Inc (LPCN)
B Purchase
75,000 +5.3%
0.39
USD 29,250 		75,000 +5.3% 0.39 USD 29,250
2022-09-27 2022-09-27
US Lipocine Inc (LPCN)
B Purchase
100,000 +7.7%
0.41
USD 41,000 		100,000 +7.7% 0.41 USD 41,000
2022-05-16 2022-05-16
US Lipocine Inc (LPCN)
B Purchase
50,000 +4.0%
0.77
USD 38,495 		50,000 +4.0% 0.77 USD 38,495
2021-11-18 2021-11-18
US Lipocine Inc (LPCN)
B Purchase
25,000 +2.0%
1.09
USD 27,250 		25,000 +2.0% 1.09 USD 27,250
2020-12-17 2020-12-16
US Lipocine Inc (LPCN)
PS Planned sale
15,000 -1.2%
1.35
USD 20,250 		15,000 -1.2% 1.35 USD 20,250
2020-12-08 2020-12-04
US Lipocine Inc (LPCN)
PS Planned sale
43,500 -3.9%
1.57
USD 68,134 		43,500 -3.9% 1.57 USD 68,134
2020-01-02 2019-12-31
US Lipocine Inc (LPCN)
B Purchase
40,000 +4.3%
0.38
USD 15,340 		40,000 +4.3% 0.38 USD 15,340
2019-12-10 2019-12-10
US Lipocine Inc (LPCN)
B Purchase
25,000 +2.8%
0.40
USD 9,975 		25,000 +2.8% 0.40 USD 9,975
2019-12-06 2019-12-04
US Lipocine Inc (LPCN)
PS Planned sale
43,500 -4.6%
0.41
USD 17,835 		43,500 -4.6% 0.41 USD 17,835
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
21,928 +2.8%
0.43
USD 9,385 		21,928 +2.8% 0.43 USD 9,385
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
1,100 +0.1%
0.43
USD 470 		1,100 +0.1% 0.43 USD 470
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
700 +0.1%
0.43
USD 299 		700 +0.1% 0.43 USD 299
2019-11-26 2019-11-26
US Lipocine Inc (LPCN)
B Purchase
1,272 +0.2%
0.43
USD 543 		1,272 +0.2% 0.43 USD 543
2019-11-18 2019-11-18
US Lipocine Inc (LPCN)
B Purchase
4,810 +0.6%
0.42
USD 2,019 		4,810 +0.6% 0.42 USD 2,019
2019-11-18 2019-11-18
US Lipocine Inc (LPCN)
B Purchase
40,259 +5.5%
0.40
USD 16,104 		40,259 +5.5% 0.40 USD 16,104
2019-11-18 2019-11-18
US Lipocine Inc (LPCN)
B Purchase
4,931 +0.7%
0.40
USD 1,972 		4,931 +0.7% 0.40 USD 1,972
2018-01-02 2017-12-29
US Lipocine Inc (LPCN)
PS Planned sale
6,000 -0.8%
3.48
USD 20,867 		6,000 -0.8% 3.48 USD 20,867
2015-10-02 2015-09-30
US Lipocine Inc (LPCN)
B Purchase
1,300 +0.1%
11.68
USD 15,179 		1,300 +0.1% 11.68 USD 15,179
2015-10-02 2015-09-30
US Lipocine Inc (LPCN)
B Purchase
700 +0.1%
11.68
USD 8,176 		700 +0.1% 11.68 USD 8,176
2015-10-02 2015-09-30
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
12.00
USD 24,000 		2,000 +0.2% 12.00 USD 24,000
2014-11-25 2014-11-25
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
5.10
USD 10,200 		2,000 +0.2% 5.10 USD 10,200
2014-11-24 2014-11-24
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
5.45
USD 10,900 		2,000 +0.2% 5.45 USD 10,900
2014-11-14 2014-11-14
US Lipocine Inc (LPCN)
B Purchase
100 +0.0%
5.06
USD 506 		100 +0.0% 5.06 USD 506
2014-11-14 2014-11-14
US Lipocine Inc (LPCN)
B Purchase
1,900 +0.2%
5.06
USD 9,614 		1,900 +0.2% 5.06 USD 9,614
2014-11-13 2014-11-13
US Lipocine Inc (LPCN)
B Purchase
2,000 +0.2%
5.05
USD 10,104 		2,000 +0.2% 5.05 USD 10,104
// ... existing code ... // ... rest of the file ...